230, Bernard-Belleau Street, Suite 121
Laval , H7V 4A9

Phone: (450) 686-9440
Fax: (450) 686-4980


BioQuadrant is a chemistry-based service provider to the biotech and pharmaceutical industry, specializing in drug discovery, contract research and preclinical small-scale production of API up to kilogram-level. The company is based in Laval, QC, Canada, one of North America’s fastest growing and most successful biotechnology hubs. BioQuadrant’s unique approach focusses on preclinical chemical process development and production of active ingredients for preclinical trials, thereby allowing it’s clients to make the critical transition from lab bench to preclinical trials in the shortest time and at a competitive cost thanks to Canada’s unique scientific research and experimental development tax credits. The company was founded in 1999, and has successfully completed numerous projects in a variety of therapeutic areas. The company has established unique expertise and capabilities in the field of HIV protease inhibitors, cardiovascular drugs, ophthomology, analegics and sedatives, anticonvulsants, anti-diabetes and anti-obesity drugs. Our proven track record in the field of preclinical chemistry, combined with our in-house expertise in the creation of new building blocks and pharmaceutical intermediates, make BioQuadrant a perfect partner for start-up and emerging companies.